2509. Pooled Resistance Analyses of Darunavir (DRV) Once Daily (QD) Regimens and Formulations Across 10 Clinical Studies of Treatment-Naïve (TN) and Treatment-Experienced (TE) Patients with Human Immunodeficiency Virus (HIV)-1 Infection

BACKGROUND: DRV has demonstrated high efficacy and barrier to resistance development across diverse populations, from TN to heavily TE patients. We evaluated resistance data from 10 clinical studies of different DRV 800 mg QD–based antiretroviral regimens and formulations. METHODS: The analysis incl...

Descripción completa

Detalles Bibliográficos
Autores principales: Lathouwers, Erkki, Seyedkazemi, Sareh, Luo, Donghan, Brown, Kimberley, De Meyer, Sandra, Wong, Eric Y
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810668/
http://dx.doi.org/10.1093/ofid/ofz360.2187

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810668/
http://dx.doi.org/10.1093/ofid/ofz360.2187

Ejemplares similares